GO:1905032 negative regulation of membrane repolarization during cardiac muscle cell action potential: Ion Channel Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905032 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of membrane repolarization during a cardiac muscle cell action potential.
• Repolarization of the cardiac action potential is driven by the coordinated activity of potassium currents, including IKr, IKs, and Ito, which are themselves targets of negative regulation.
• The Ca2+-dependent regulation of IKs and the interplay between RyR2-mediated Ca2+ release and Cx43 hemichannels illustrate how intracellular calcium can modulate repolarization.
• Transcription factors such as Irx5 establish the ventricular repolarization gradient by negatively regulating repolarization in specific myocardial layers.
• Pharmacological agents and toxins, such as lindane, can inhibit repolarizing currents and thereby prolong the action potential, demonstrating the physiological relevance of negative regulation.
• Dysregulation of repolarization is linked to arrhythmias, making GO:1905032 a key term for cardiac safety pharmacology and inherited arrhythmia research.
Description
The cardiac action potential is a finely orchestrated electrical signal whose duration and shape are determined by the balance between depolarizing and repolarizing currents. Repolarization, the phase during which the cell returns to its resting membrane potential, is primarily mediated by potassium efflux through a variety of channels. GO:1905032, negative regulation of membrane repolarization during cardiac muscle cell action potential, encompasses any process that reduces the frequency, rate, or extent of this repolarization phase. Understanding this term is essential because even subtle changes in repolarization can predispose to life-threatening arrhythmias. Research into GO:1905032 has revealed multiple layers of control, from the biophysical properties of ion channels to calcium-dependent signaling and transcriptional regulation. For example, the slow delayed rectifier potassium current IKs is modulated by intracellular calcium, providing a feedback mechanism that can negatively regulate repolarization. Similarly, the transcription factor Irx5 establishes a gradient of repolarization across the ventricular wall by suppressing repolarizing currents in a layer-specific manner. These findings highlight that negative regulation of repolarization is not a single event but a network of interacting processes. For biomedical researchers, GO:1905032 provides a conceptual framework to study how genetic variants, drugs, or toxins alter cardiac electrical behavior. By focusing on the processes that inhibit repolarization, one can identify novel targets for antiarrhythmic therapy or predict adverse drug reactions. This article synthesizes current knowledge on the mechanisms, genes, and experimental models relevant to GO:1905032, with an emphasis on CRISPR-based approaches for functional validation.
negative regulation of membrane repolarization during cardiac muscle cell action potential At A Glance
| GO ID | GO:1905032 |
|---|---|
| GO term | negative regulation of membrane repolarization during cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | down regulation of membrane repolarization during cardiac muscle cell action potential; down-regulation of membrane repolarization during cardiac muscle cell action potential; downregulation of membrane repolarization during cardiac muscle cell action potential; inhibition of membrane repolarization during cardiac muscle cell action potential |
| Major function | To reduce the rate or extent of membrane repolarization in cardiac muscle cells, thereby prolonging the action potential duration. |
| Related cellular component | Cardiac muscle cell membrane (sarcolemma), ion channels (e.g., Kv7.1, Kv11.1), and associated regulatory proteins. |
| Related molecular function | Ion channel activity, particularly potassium channel activity, and calcium-dependent regulation. |
| Related biological process | Cardiac muscle cell action potential, regulation of membrane repolarization, regulation of heart rate. |
What Is GO:1905032?
GO:1905032 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of membrane repolarization during a cardiac muscle cell action potential. In simpler terms, it covers all biological mechanisms that slow down or inhibit the return of a heart muscle cell's membrane potential to its resting state after an action potential. This includes modulation of ion channels, signaling pathways, and transcriptional programs that ultimately decrease the efficiency of repolarization.
Why Is negative regulation of membrane repolarization during cardiac muscle cell action potential Important in Cell Biology?
GO:1905032 is critically important because repolarization abnormalities are directly linked to cardiac arrhythmias and sudden cardiac death. Negative regulation of repolarization can be protective or pathological depending on context; for instance, slowing repolarization can reduce excitability during certain arrhythmias, but excessive prolongation increases the risk of early afterdepolarizations and torsades de pointes. Understanding the processes that negatively regulate repolarization helps researchers identify therapeutic targets and predict drug cardiotoxicity.
• Provides a mechanistic framework for understanding how potassium currents such as IKs and IKr are modulated.
• Explains the role of calcium signaling, including RyR2 and Cx43 hemichannels, in regulating repolarization.
• Links transcriptional regulation (e.g., Irx5) to regional differences in repolarization across the ventricular wall.
• Helps interpret the effects of pharmacological agents and toxins that inhibit repolarizing currents.
• Guides the development of antiarrhythmic drugs that target specific repolarization pathways.
• Supports cardiac safety pharmacology by predicting drug-induced QT prolongation.
• Facilitates the study of inherited arrhythmia syndromes such as long QT syndrome.
• Enables the identification of genetic variants that alter repolarization reserve.
• Provides a basis for CRISPR-based functional studies of repolarization genes.
• Informs computational models of cardiac electrophysiology by defining regulatory inputs.
What Happens During negative regulation of membrane repolarization during cardiac muscle cell action potential?
Initiation of repolarization and its negative regulation
In simple terms: Repolarization starts when potassium ions leave the cell, but negative regulation slows this process down.
During the plateau phase of the cardiac action potential, repolarization is initiated by the inactivation of L-type calcium channels and the activation of potassium currents. Negative regulation of repolarization can occur through inhibition of these potassium currents or enhancement of inward depolarizing currents. For example, the slow delayed rectifier current IKs is a major contributor to repolarization, and its reduction directly slows repolarization. The biophysical properties of IKs, including its calcium-dependent activation, provide a means for negative regulation under conditions of altered intracellular calcium.
Calcium-dependent modulation of repolarizing currents
In simple terms: Calcium inside the cell can change how potassium channels work, often slowing repolarization.
Intracellular calcium plays a dual role in repolarization. On one hand, calcium activates IKs through calmodulin-dependent mechanisms, which would accelerate repolarization. On the other hand, calcium release from the sarcoplasmic reticulum via RyR2 can activate Cx43 hemichannels, leading to changes in membrane potential that may oppose repolarization. The interplay between these calcium-dependent pathways can result in negative regulation of repolarization, particularly under pathological conditions such as calcium overload.
Transcriptional control of repolarization gradients
In simple terms: Certain genes act as master switches that create regional differences in repolarization speed.
The homeodomain transcription factor Irx5 establishes a gradient of repolarization across the ventricular wall by differentially regulating potassium channel expression. In the mouse heart, Irx5 negatively regulates the expression of Kv4.2 (KCND2), a channel responsible for the transient outward current Ito, in a layer-specific manner. This transcriptional repression creates a transmural gradient of repolarization, which is essential for normal cardiac function. Disruption of this gradient can lead to arrhythmias, highlighting the importance of transcriptional negative regulation in GO:1905032.
Pharmacological and toxicological inhibition of repolarization
In simple terms: Many drugs and toxins can block potassium channels, slowing repolarization and potentially causing arrhythmias.
A wide range of pharmacological agents and environmental toxins can negatively regulate repolarization by inhibiting potassium currents. For instance, lindane, a gamma isomer of hexachlorocyclohexane, has been shown to alter cardiac action potential repolarization, likely through effects on ion channels. Such inhibition can prolong the QT interval and increase the risk of torsades de pointes. Understanding these pharmacological effects is crucial for drug safety assessment and for developing therapeutic strategies that target specific repolarizing currents.
Regulation of channel surface expression and localization
In simple terms: The number of potassium channels on the cell surface can be reduced, which slows repolarization.
Negative regulation of repolarization can also occur at the level of channel trafficking and surface expression. For example, the small-conductance calcium-activated potassium channel SK2 (KCNN2) is regulated by interacting proteins such as alpha-actinin2 and filamin A, which influence its surface membrane expression. Reduced surface expression of SK2 would decrease the repolarizing current, thereby negatively regulating repolarization. Similar mechanisms may apply to other potassium channels, providing a post-translational layer of control.
Key Genes Involved in GO:1905032 negative regulation of membrane repolarization during cardiac muscle cell action potential
The following genes and proteins are central to the negative regulation of membrane repolarization during cardiac muscle cell action potential, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNQ1 | Encodes Kv7.1, the alpha subunit of the slow delayed rectifier potassium channel IKs; its inhibition reduces repolarization. | Target for antiarrhythmic drugs and long QT syndrome research. |
| KCNH2 | Encodes Kv11.1 (hERG), the alpha subunit of the rapid delayed rectifier potassium current IKr; blockade prolongs repolarization. | Major off-target for drug cardiotoxicity and inherited long QT syndrome. |
| KCNE1 | Beta subunit that assembles with Kv7.1 to form IKs; modulates channel kinetics and calcium sensitivity. | Modifies IKs function and repolarization reserve. |
| RYR2 | Ryanodine receptor 2; mediates calcium release from sarcoplasmic reticulum, which can activate Cx43 hemichannels and affect repolarization. | Links calcium handling to repolarization and arrhythmias. |
| GJA1 | Encodes connexin 43 (Cx43); hemichannel activation by RyR2-mediated calcium release can influence membrane potential. | Role in cardiac conduction and repolarization. |
| IRX5 | Transcription factor that represses KCND2 expression, establishing the ventricular repolarization gradient. | Key regulator of regional repolarization differences. |
| KCND2 | Encodes Kv4.2, the alpha subunit of the transient outward potassium current Ito; its repression slows early repolarization. | Target of Irx5-mediated negative regulation. |
| KCNN2 | Encodes SK2, a calcium-activated potassium channel; its surface expression is regulated by interacting proteins. | Modulates repolarization and is regulated by alpha-actinin2 and filamin A. |
| ACTN2 | Encodes alpha-actinin2, an actin-binding protein that interacts with SK2 and regulates its surface expression. | Modifies SK2 function and repolarization. |
| FLNA | Encodes filamin A, an actin-binding protein that interacts with SK2 and regulates its surface expression. | Modifies SK2 function and repolarization. |
| CALM1 | Calmodulin 1; mediates calcium-dependent regulation of IKs and other channels. | Central to calcium-dependent modulation of repolarization. |
| CALM2 | Calmodulin 2; similar to CALM1, involved in calcium sensing for ion channels. | Potential modifier of repolarization. |
| CALM3 | Calmodulin 3; participates in calcium-dependent regulation of cardiac ion channels. | Potential modifier of repolarization. |
| SCN5A | Encodes the cardiac sodium channel Nav1.5; late sodium current can oppose repolarization. | Involved in long QT syndrome and arrhythmias. |
| CACNA1C | Encodes the L-type calcium channel Cav1.2; its activity during the plateau influences repolarization. | Target for calcium channel blockers and arrhythmia research. |
| KCNA4 | Encodes Kv1.4, a component of Ito in some species; contributes to early repolarization. | Species-specific role in repolarization. |
| KCNA5 | Encodes Kv1.5, which underlies the ultrarapid delayed rectifier current IKur in atrial myocytes. | Atrial repolarization and atrial fibrillation research. |
| KCNJ2 | Encodes Kir2.1, the inward rectifier current IK1; sets resting membrane potential and contributes to final repolarization. | Mutations cause Andersen-Tawil syndrome. |
How Is negative regulation of membrane repolarization during cardiac muscle cell action potential Regulated?
The negative regulation of membrane repolarization is itself regulated at multiple levels. Transcriptional control by factors such as Irx5 establishes regional differences in repolarization. Post-translational modifications and interacting proteins, such as alpha-actinin2 and filamin A, regulate the surface expression of SK2 channels. Calcium-dependent signaling pathways, including calmodulin and RyR2-mediated calcium release, modulate the activity of repolarizing currents. Additionally, pharmacological agents can acutely inhibit repolarizing currents, providing a form of external regulation. These layers of regulation ensure that repolarization is finely tuned to meet the physiological demands of the heart.
negative regulation of membrane repolarization during cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNQ1 | Long QT syndrome type 1; loss-of-function reduces IKs and delays repolarization. | Knockout or point-mutation iPSC-derived cardiomyocytes. |
| KCNH2 | Long QT syndrome type 2 and drug-induced arrhythmia; blockade of IKr prolongs repolarization. | Knock-in of hERG mutations in HEK293 or cardiomyocytes. |
| RYR2 | CPVT and calcium-dependent arrhythmias; altered calcium release affects repolarization. | Knock-in mouse models or patient-derived iPSC cardiomyocytes. |
| IRX5 | Modulates ventricular repolarization gradient; dysfunction may predispose to arrhythmias. | Knockout mouse models and cardiac-specific overexpression. |
| GJA1 | Connexin 43 hemichannel activation linked to arrhythmias; affects membrane potential. | Conditional knockout or overexpression in cardiomyocytes. |
Long QT syndrome and arrhythmias
Long QT syndrome (LQTS) is a disorder characterized by prolonged ventricular repolarization, which can lead to torsades de pointes and sudden cardiac death. Both inherited mutations in potassium channel genes (e.g., KCNQ1, KCNH2) and acquired factors (e.g., drugs) that negatively regulate repolarization contribute to LQTS. Understanding GO:1905032 is therefore essential for diagnosing and managing LQTS.
Drug-induced cardiotoxicity
Many pharmacological agents inadvertently inhibit repolarizing currents, leading to QT prolongation and arrhythmia risk. For example, lindane has been shown to affect cardiac repolarization. The hERG channel (KCNH2) is particularly notorious for binding to drugs and causing cardiotoxicity. Studying negative regulation of repolarization helps in predicting and mitigating these adverse effects.
Calcium handling disorders and arrhythmias
Abnormal calcium release through RyR2 can activate Cx43 hemichannels and alter repolarization, contributing to arrhythmias in conditions such as catecholaminergic polymorphic ventricular tachycardia (CPVT) and heart failure. The interplay between calcium signaling and repolarization highlights the importance of GO:1905032 in calcium-related cardiac diseases.
From negative regulation of membrane repolarization during cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KCNQ1 reduce IKs and slow repolarization? | KCNQ1 knockout iPSC-derived cardiomyocytes or HEK293 cells. |
| How does a specific KCNH2 mutation affect IKr kinetics? | Point-mutation knock-in in HEK293 cells or cardiomyocytes. |
| Can overexpression of Irx5 alter the repolarization gradient? | Cardiac-specific overexpression in mouse models. |
| What is the role of RyR2 in calcium-dependent repolarization changes? | RyR2 knockout or point-mutation knock-in cardiomyocytes. |
| Does tagging SK2 with a fluorescent protein affect its trafficking? | Tagged knock-in of KCNN2 in cardiomyocytes. |
| Can CRISPR library screening identify novel regulators of repolarization? | Genome-wide CRISPR knockout library in cardiomyocytes followed by electrophysiology. |
How to Study the negative regulation of membrane repolarization during cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Action potential duration and ionic currents | Quantifying negative regulation of repolarization. |
| Calcium imaging | Intracellular calcium transients | Linking calcium signaling to repolarization. |
| RNA sequencing | Gene expression changes | Identifying transcriptional regulators like Irx5. |
| Proteomics | Protein interactions and abundance | Discovering SK2-interacting proteins. |
| CRISPR knockout screening | Loss-of-function phenotypes | Finding novel repolarization regulators. |
| CRISPR point mutation | Specific amino acid changes | Modeling inherited arrhythmia mutations. |
| CRISPR knock-in | Tagged or reporter alleles | Tracking channel localization and trafficking. |
| Voltage-sensitive dyes | Membrane potential changes in cell populations | High-throughput screening of repolarization modulators. |
Electrophysiological recordings
Patch-clamp techniques are the gold standard for measuring action potentials and ion currents in cardiomyocytes. Voltage-clamp allows detailed analysis of specific currents such as IKs and IKr, enabling quantification of negative regulation. These methods are essential for validating findings from genetic or pharmacological studies.
Calcium imaging and signaling assays
Calcium imaging using fluorescent dyes or genetically encoded indicators can reveal how intracellular calcium dynamics influence repolarization. Combining calcium imaging with electrophysiology provides a comprehensive view of excitation-contraction coupling and its impact on repolarization.
Transcriptional and proteomic profiling
RNA sequencing and proteomics can identify changes in gene and protein expression that underlie negative regulation of repolarization. For example, Irx5 target genes can be identified by RNA-seq in knockout models. Proteomic approaches can reveal interacting partners of ion channels, such as alpha-actinin2 and filamin A with SK2.
CRISPR-based functional genomics
CRISPR knockout, point mutation, and knock-in models allow precise manipulation of genes involved in repolarization. These models can be used in high-throughput screens to identify novel regulators of GO:1905032. For instance, a CRISPR library screen in cardiomyocytes coupled with voltage-sensitive dyes could uncover genes whose loss alters repolarization.
How CRISPR Can Be Used to Study GO:1905032 negative regulation of membrane repolarization during cardiac muscle cell action potential
Knockout
CRISPR knockout of genes such as KCNQ1, KCNH2, or IRX5 in cardiomyocytes can reveal their contribution to negative regulation of repolarization. For example, KCNQ1 knockout abolishes IKs, leading to prolonged action potentials. These models are valuable for target validation and drug testing.
Point Mutation
Introducing disease-associated point mutations (e.g., in KCNH2 or SCN5A) using CRISPR allows precise modeling of inherited arrhythmia syndromes. Such models can be used to test the effects of specific mutations on repolarization and to screen for corrective drugs.
Knock-in
Knock-in of reporter tags (e.g., fluorescent proteins) into endogenous loci such as KCNN2 enables real-time tracking of channel trafficking and localization. This approach can reveal how surface expression of repolarizing channels is regulated.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression can be used to increase the expression of genes that negatively regulate repolarization, such as IRX5. Overexpression models help establish sufficiency of a gene in modulating repolarization.
How EDITGENE Supports negative regulation of membrane repolarization during cardiac muscle cell action potential Research
Researchers studying negative regulation of membrane repolarization during cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in modulating repolarization. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of membrane repolarization during cardiac muscle cell action potential research.
Frequently Asked Questions About negative regulation of membrane repolarization during cardiac muscle cell action potential
What is GO:1905032?
GO:1905032 is a Gene Ontology term for any process that stops, prevents, or reduces the frequency, rate, or extent of membrane repolarization during a cardiac muscle cell action potential.
What genes are involved in negative regulation of membrane repolarization during cardiac muscle cell action potential?
Key genes include KCNQ1, KCNH2, KCNE1, RYR2, GJA1, IRX5, KCND2, KCNN2, and others that encode ion channels or regulatory proteins.
How does calcium signaling affect cardiac repolarization?
Calcium can activate IKs through calmodulin and also trigger RyR2-mediated Cx43 hemichannel activation, both of which can modulate repolarization.
What diseases are associated with abnormal repolarization?
Long QT syndrome, drug-induced arrhythmias, and calcium handling disorders such as CPVT are linked to altered repolarization.
Which potassium currents are responsible for repolarization?
The rapid (IKr) and slow (IKs) delayed rectifier currents, as well as the transient outward current (Ito), are major repolarizing currents.
How can CRISPR be used to study repolarization?
CRISPR knockout, point mutation, and knock-in can create isogenic models to test the role of specific genes in repolarization.
What is the role of Irx5 in repolarization?
Irx5 is a transcription factor that represses KCND2, creating a transmural gradient of repolarization in the heart.
What experimental models are used to study GO:1905032?
Patch-clamp electrophysiology, calcium imaging, RNA-seq, proteomics, and CRISPR-engineered cardiomyocytes are commonly used.
Can drugs cause negative regulation of repolarization?
Yes, many drugs inhibit potassium channels such as hERG, leading to prolonged repolarization and increased arrhythmia risk.
How does SK2 channel regulation affect repolarization?
SK2 surface expression is regulated by alpha-actinin2 and filamin A; reduced expression decreases repolarizing current.
Conclusion
GO:1905032, negative regulation of membrane repolarization during cardiac muscle cell action potential, is a critical biological process that underlies both normal cardiac physiology and arrhythmia susceptibility. The interplay of ion channels, calcium signaling, and transcriptional programs ensures precise control of repolarization, and its disruption can lead to life-threatening conditions. Continued research using advanced CRISPR models and electrophysiological techniques will further elucidate these mechanisms and aid in the development of safer therapeutics.
References
- 1. Varró A et al.. 1992. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.. Cardioscience 3(3):131-44 PMID: 1384746
- 2. Mackie AR et al.. 2008. Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention.. Mol Pharmacol 74(5):1171-9 PMID: 18684841
- 3. Bartos DC et al.. 2017. Quantitative analysis of the Ca(2+) -dependent regulation of delayed rectifier K(+) current I(Ks) in rabbit ventricular myocytes.. J Physiol 595(7):2253-2268 PMID: 28008618
- 4. Lissoni A et al.. 2021. RyR2 regulates Cx43 hemichannel intracellular Ca2+-dependent activation in cardiomyocytes.. Cardiovasc Res 117(1):123-136 PMID: 31841141
- 5. Sauviat MP et al.. 2002. [Cardiotoxicity of lindane, a gamma isomer of hexachlorocyclohexane].. J Soc Biol 196(4):339-48 PMID: 12645305
- 6. Costantini DL et al.. 2005. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient.. Cell 123(2):347-58 PMID: 16239150
- 7. Zhang Z et al.. 2017. Distinct subcellular mechanisms for the enhancement of the surface membrane expression of SK2 channel by its interacting proteins, α-actinin2 and filamin A.. J Physiol 595(7):2271-2284 PMID: 27779751
